AI-Driven Drug Discovery using Metabolomics
Contact us to add description.
ReviveMed is a precision medicine company that uses metabolomics to develop new treatments for liver diseases. The company's technology can identify more than 10,000 metabolites per patient, providing 20 times more data than any other platform. This wealth of data allows ReviveMed to develop personalized treatments for each patient. ReviveMed is currently focused on developing treatments for non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). NASH is a chronic liver disease that is caused by a buildup of fat in the liver. PSC is a chronic liver disease that is caused by inflammation of the bile ducts.